Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4.


Journal

Cell chemical biology
ISSN: 2451-9448
Titre abrégé: Cell Chem Biol
Pays: United States
ID NLM: 101676030

Informations de publication

Date de publication:
16 06 2022
Historique:
received: 06 04 2021
revised: 19 11 2021
accepted: 11 01 2022
pubmed: 13 2 2022
medline: 22 6 2022
entrez: 12 2 2022
Statut: ppublish

Résumé

Signal transduction pathways post-translationally regulating nucleotide metabolism remain largely unknown. Guanosine monophosphate reductase (GMPR) is a nucleotide metabolism enzyme that decreases GTP pools by converting GMP to IMP. We observed that phosphorylation of GMPR at Tyr267 is critical for its activity and found that this phosphorylation by ephrin receptor tyrosine kinase EPHA4 decreases GTP pools in cell protrusions and levels of GTP-bound RAC1. EPHs possess oncogenic and tumor-suppressor activities, although the mechanisms underlying switches between these two modes are poorly understood. We demonstrated that GMPR plays a key role in EPHA4-mediated RAC1 suppression. This supersedes GMPR-independent activation of RAC1 by EPHA4, resulting in a negative overall effect on melanoma cell invasion and tumorigenicity. Accordingly, EPHA4 levels increase during melanoma progression and inversely correlate with GMPR levels in individual melanoma tumors. Therefore, phosphorylation of GMPR at Tyr267 is a metabolic signal transduction switch controlling GTP biosynthesis and transformed phenotypes.

Identifiants

pubmed: 35148834
pii: S2451-9456(22)00049-6
doi: 10.1016/j.chembiol.2022.01.007
pmc: PMC9620470
mid: NIHMS1780090
pii:
doi:

Substances chimiques

Nucleotides 0
Guanosine Triphosphate 86-01-1
GMP Reductase EC 1.7.1.7
Receptor, EphA4 EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

970-984.e6

Subventions

Organisme : NCI NIH HHS
ID : R01 CA264984
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA248018
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA224434
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA012197
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM054403
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125362
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062617
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA247819
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing financial interests.

Références

Mol Cell Biol. 2000 Jul;20(13):4791-805
pubmed: 10848605
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8328-33
pubmed: 17494752
J Cell Biochem. 2017 Mar;118(3):442-445
pubmed: 27632701
Biochemistry. 2018 Jun 5;57(22):3146-3154
pubmed: 29547266
Nat Commun. 2021 Oct 19;12(1):6091
pubmed: 34667203
Cell Death Differ. 2015 Nov;22(11):1858-64
pubmed: 25909885
Cell. 2007 Aug 24;130(4):742-53
pubmed: 17719550
Semin Cell Dev Biol. 2012 Feb;23(1):7-15
pubmed: 22044886
Cell Metab. 2018 Sep 4;28(3):369-382.e5
pubmed: 30043754
Nat Commun. 2020 Jul 30;11(1):3811
pubmed: 32732914
Sci Rep. 2020 Feb 6;10(1):1971
pubmed: 32029850
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):912-7
pubmed: 23284172
Biochem J. 1972 Apr;127(3):597-605
pubmed: 4672799
Cancer Res. 2014 Sep 1;74(17):4845-4852
pubmed: 25056119
Cancer Cell. 2019 Jul 8;36(1):68-83.e9
pubmed: 31257073
Semin Cell Dev Biol. 2012 Feb;23(1):1-6
pubmed: 22040913
Mol Cell Biol. 2000 Oct;20(19):7160-9
pubmed: 10982832
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Cancer Sci. 2006 Nov;97(11):1211-6
pubmed: 16965393
Mol Cancer Ther. 2012 Sep;11(9):2021-32
pubmed: 22807579
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33079728
Nat Commun. 2015 Jun 12;6:7389
pubmed: 26067754
Sci Rep. 2018 Feb 9;8(1):2759
pubmed: 29426890
Cell. 2003 Jul 11;114(1):33-45
pubmed: 12859896
Neuron. 2001 Jan;29(1):73-84
pubmed: 11182082
Cell Cycle. 2008 Aug;7(15):2392-400
pubmed: 18677108
FEBS Lett. 2003 Dec 18;555(3):556-60
pubmed: 14675773
Neuron. 2005 Apr 21;46(2):205-17
pubmed: 15848800
J Cell Biol. 2000 Apr 17;149(2):263-70
pubmed: 10769020
Eur J Immunol. 2007 Aug;37(8):2326-36
pubmed: 17634955
Cell Rep. 2013 Oct 31;5(2):493-507
pubmed: 24139804
FEBS J. 2017 Jul;284(14):2148-2162
pubmed: 28196297
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Oncogene. 2011 Dec 15;30(50):4921-9
pubmed: 21666714
Pigment Cell Res. 2007 Jun;20(3):161-72
pubmed: 17516924
Nat Commun. 2019 Apr 29;10(1):1977
pubmed: 31036831
J Cell Biol. 2019 Sep 2;218(9):3077-3097
pubmed: 31420453
Mol Biol Cell. 2001 Feb;12(2):265-77
pubmed: 11179414
J Biol Chem. 1979 Apr 10;254(7):2308-15
pubmed: 218932
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
J Biol Chem. 2000 Aug 18;275(33):25299-307
pubmed: 10843989
J Neurosci. 2020 Sep 9;40(37):7091-7104
pubmed: 32801149
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16347-52
pubmed: 17911252
Anticancer Res. 2021 Apr;41(4):1733-1744
pubmed: 33813377
Front Biosci (Landmark Ed). 2012 Jan 01;17(2):473-97
pubmed: 22201756
Neuron. 2007 Sep 6;55(5):756-67
pubmed: 17785182
Clin Ther. 2015 Mar 1;37(3):682-5
pubmed: 25465943
PLoS One. 2012;7(5):e36739
pubmed: 22606284
J Leukoc Biol. 2008 Oct;84(4):1183-91
pubmed: 18593733
Nat Chem Biol. 2020 Aug;16(8):826-833
pubmed: 32424303
Cancers (Basel). 2019 May 17;11(5):
pubmed: 31108873
Small GTPases. 2017 Jul 3;8(3):139-163
pubmed: 27442895
Crit Rev Biochem Mol Biol. 2012 May-Jun;47(3):250-63
pubmed: 22332716
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
Nat Rev Cancer. 2010 Mar;10(3):165-80
pubmed: 20179713
Neuron. 2007 Sep 6;55(5):768-78
pubmed: 17785183
Mol Cell Biochem. 2018 Feb;439(1-2):95-104
pubmed: 28795314
Nat Rev Mol Cell Biol. 2005 Feb;6(2):167-80
pubmed: 15688002
Dev Cell. 2004 Oct;7(4):465-80
pubmed: 15469835
Oncogene. 2017 Jan 5;36(1):84-96
pubmed: 27181209
F1000Res. 2016 Mar 30;5:
pubmed: 27092247
Neuron. 2005 Apr 21;46(2):191-204
pubmed: 15848799
Mol Cancer Ther. 2013 Oct;12(10):1925-34
pubmed: 24072884
J Neurosci. 2015 Feb 11;35(6):2344-57
pubmed: 25673830
Oncogene. 2019 Sep;38(39):6567-6584
pubmed: 31406248
Org Biomol Chem. 2018 Jul 18;16(28):5167-5177
pubmed: 29971290
J Invest Dermatol. 2021 Apr;141(4):840-851.e4
pubmed: 32890629
FEBS Lett. 2000 Aug 4;478(3):253-9
pubmed: 10930578
Cancer Res. 2018 Jan 1;78(1):216-229
pubmed: 29093007
Cell Rep. 2017 Jun 27;19(13):2665-2680
pubmed: 28658616
Elife. 2020 Apr 07;9:
pubmed: 32254022
Mol Biochem Parasitol. 1987 May;24(1):1-12
pubmed: 2886911
Dev Biol. 2019 Mar 1;447(1):42-57
pubmed: 29360434
Mol Med Rep. 2021 Jan;23(1):
pubmed: 33236144
Front Cell Dev Biol. 2020 Apr 03;8:222
pubmed: 32309283
Nat Methods. 2017 Oct;14(10):1003-1009
pubmed: 28869758
Cells. 2019 Apr 26;8(5):
pubmed: 31027363
Nat Genet. 2012 Sep;44(9):1006-14
pubmed: 22842228
Nat Cell Biol. 2019 Aug;21(8):1003-1014
pubmed: 31371825
Circ Res. 2003 Jul 11;93(1):23-31
pubmed: 12775584
J Biol Chem. 2021 Jul;297(1):100876
pubmed: 34139238
Cancer Discov. 2015 Mar;5(3):274-87
pubmed: 25542448
Mol Cancer Ther. 2014 Jul;13(7):1918-28
pubmed: 24755198
J Cell Biol. 2018 Feb 5;217(2):447-457
pubmed: 29233866
Cell Adh Migr. 2012 Mar-Apr;6(2):138-47
pubmed: 22568950
Mol Cell Biochem. 1994 Nov 9;140(1):1-22
pubmed: 7877593
Br J Cancer. 1994 Mar;69(3):417-21
pubmed: 8123468
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W457-61
pubmed: 20460459
RNA. 2003 Apr;9(4):493-501
pubmed: 12649500
Dev Cell. 2015 Nov 9;35(3):344-57
pubmed: 26555054
Eur Biophys J. 2002 Jul;31(4):268-74
pubmed: 12122473
Nat Chem Biol. 2011 Oct 30;7(12):950-8
pubmed: 22037469
Nat Rev Cancer. 2013 Dec;13(12):827-41
pubmed: 24263188
FEBS J. 2009 Aug;276(16):4395-404
pubmed: 19678838
PLoS One. 2008 Jul 16;3(7):e2722
pubmed: 18628958
Nature. 2009 Sep 3;461(7260):99-103
pubmed: 19693013
J Biol Chem. 1998 Apr 10;273(15):8776-82
pubmed: 9535855
Expert Opin Investig Drugs. 2020 Jun;29(6):567-582
pubmed: 32348169
Cell. 2008 Apr 4;133(1):38-52
pubmed: 18394988
J Am Chem Soc. 2016 Mar 2;138(8):2571-5
pubmed: 26863024
Mol Cell Biol. 2006 Jul;26(13):4830-42
pubmed: 16782872
Cancer Cell. 2017 Nov 13;32(5):624-638.e5
pubmed: 29056426
J Mol Biol. 2006 Feb 3;355(5):980-8
pubmed: 16359702
J Biol Chem. 2006 Oct 27;281(43):32574-86
pubmed: 16950769
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7
pubmed: 15980490
Clin Exp Metastasis. 2012 Oct;29(7):775-96
pubmed: 22892755

Auteurs

David W Wolff (DW)

Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Zhiyong Deng (Z)

Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Anna Bianchi-Smiraglia (A)

Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.

Colleen E Foley (CE)

Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.

Zhannan Han (Z)

Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Xingyou Wang (X)

Department of Chemistry, Brandeis University, Waltham, MA 02453, USA.

Shichen Shen (S)

Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA.

Masha M Rosenberg (MM)

Department of Biology, Brandeis University, Waltham, MA 02453, USA.

Sudha Moparthy (S)

Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Dong Hyun Yun (DH)

Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Jialin Chen (J)

Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Brian K Baker (BK)

Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Matthew V Roll (MV)

Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Andrew J Magiera (AJ)

Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Jun Li (J)

Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA.

Edward Hurley (E)

Department of Biochemistry and Neurology, Hunter James Kelly Research Institute, University at Buffalo, Buffalo NY, USA.

Maria Laura Feltri (ML)

Department of Biochemistry and Neurology, Hunter James Kelly Research Institute, University at Buffalo, Buffalo NY, USA.

Anderson O Cox (AO)

Department of Internal Medicine, Section of Molecular Medicine, Wake Forest School of Medicine, Winston-Salem NC, USA.

Jingyun Lee (J)

Department of Internal Medicine, Section of Molecular Medicine, Wake Forest School of Medicine, Winston-Salem NC, USA.

Cristina M Furdui (CM)

Department of Internal Medicine, Section of Molecular Medicine, Wake Forest School of Medicine, Winston-Salem NC, USA.

Liang Liu (L)

Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Wiam Bshara (W)

Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo NY 14203, USA.

Leslie E W LaConte (LEW)

Fralin Biomedical Research Institute at Virginia Tech Carilion School of Medicine, Roanoke, VA 24016, USA.

Eugene S Kandel (ES)

Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.

Elena B Pasquale (EB)

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

Jun Qu (J)

Department of Chemistry, Brandeis University, Waltham, MA 02453, USA.

Lizbeth Hedstrom (L)

Department of Chemistry, Brandeis University, Waltham, MA 02453, USA; Department of Biology, Brandeis University, Waltham, MA 02453, USA.

Mikhail A Nikiforov (MA)

Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: mikhail.nikiforov@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH